BONK, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that BONK, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.12M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $702.0K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $202.7K | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $120.6K | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $2.88M | Apr 3, 2023 |
| FY2021 | Dec 31, 2020 | $1.07M | Mar 31, 2022 |
| FY2020 | Dec 30, 2019 | $6.5K | Apr 12, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.24M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($2.45M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($74.5K) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | ($204.5K) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $535.5K | Apr 3, 2023 |
| FY2021 | Dec 31, 2020 | $441.1K | Mar 31, 2022 |
| FY2020 | Dec 30, 2019 | $11.6K | Apr 12, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($68.19M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($49.41M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($15.08M) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | ($15.22M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($28.10M) | Apr 3, 2023 |
| FY2021 | Dec 31, 2020 | ($6.29M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($925.5K) | Apr 12, 2021 |
| FY2020 | Dec 30, 2019 | ($925.5K) | Apr 12, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $24.2K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $100.6K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $100.6K | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $1.64M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $1.08M | Apr 3, 2023 |
| FY2021 | Dec 31, 2020 | $308.4K | Mar 31, 2022 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | ($6.40M) | Apr 3, 2023 |
| FY2022 | Dec 31, 2021 | ($7.57M) | Apr 3, 2023 |
| FY2021 | Dec 31, 2020 | ($2.73M) | Mar 31, 2022 |
| FY2020 | Dec 30, 2019 | ($692.7K) | Apr 12, 2021 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2024 | $87.2K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $106.2K | Mar 28, 2025 |
| FY2022 | Dec 31, 2022 | $15.0K | Apr 3, 2023 |
| FY2022 | Dec 31, 2021 | $88.3K | Apr 3, 2023 |
| FY2021 | Dec 31, 2020 | $44.0K | Mar 31, 2022 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $40.97M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $7.34M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $12.71M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $8.69M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $18.87M | Apr 3, 2023 |
| FY2021 | Dec 31, 2020 | $6.53M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $745.8K | Apr 12, 2021 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.98M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $9.51M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $3.89M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $5.03M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $2.27M | Apr 3, 2023 |
| FY2021 | Dec 31, 2020 | $2.13M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $366.6K | Apr 12, 2021 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $35.00M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($2.17M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2023 | $8.82M | Mar 31, 2026 |
| FY2024 | Dec 31, 2022 | $3.67M | Mar 28, 2025 |
| FY2023 | Dec 31, 2021 | $16.60M | Apr 1, 2024 |
| FY2022 | Dec 31, 2020 | $4.39M | Apr 3, 2023 |
| FY2021 | Dec 31, 2019 | $379.2K | Mar 31, 2022 |
| FY2020 | Dec 31, 2018 | $184.3K | Apr 12, 2021 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.15M | Mar 31, 2026 |
| FY2024 | Dec 31, 2024 | $0 | Mar 28, 2025 |
| FY2024 | Dec 31, 2023 | $0 | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $0 | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $941.9K | Apr 3, 2023 |
| FY2021 | Dec 31, 2020 | $941.9K | Mar 31, 2022 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($183.49M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($115.09M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($65.68M) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | ($50.60M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($35.37M) | Apr 3, 2023 |
| FY2021 | Dec 31, 2020 | ($7.27M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($985.2K) | Apr 12, 2021 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $4.26M | Apr 12, 2021 |
| FY2020 | Dec 31, 2019 | $531.0K | Apr 12, 2021 |
| FY2020 | Dec 30, 2019 | $531.0K | Apr 12, 2021 |
| FY2020 | Dec 31, 2018 | $161.3K | Apr 12, 2021 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (17) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | (31) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | (1) | Apr 3, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 31, 2022 |
| FY2020 | Dec 30, 2019 | 0 | Apr 12, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (17) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | (31) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | (1) | Apr 3, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 31, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7.75M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 1.79M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 45.63M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | 22.34M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | 24.05M | Apr 3, 2023 |
| FY2021 | Dec 31, 2020 | 10.66M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | 6.89M | Apr 12, 2021 |